These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16158902)

  • 1. Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximab.
    Belknap R; Reves R; Burman W
    Int J Tuberc Lung Dis; 2005 Sep; 9(9):1057-8. PubMed ID: 16158902
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use.
    Mufti AH; Toye BW; Mckendry RR; Angel JB
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):233-8. PubMed ID: 16249064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis and granuloma formation in patients receiving anti-TNF therapy.
    Iliopoulos A; Psathakis K; Aslanidis S; Skagias L; Sfikakis PP
    Int J Tuberc Lung Dis; 2006 May; 10(5):588-90. PubMed ID: 16704045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis.
    Burr ML; Malaviya AP; Gaston JH; Carmichael AJ; Ostör AJ
    Rheumatology (Oxford); 2008 May; 47(5):738-9. PubMed ID: 18375402
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic tuberculosis in a patient treated with infliximab.
    Morisawa T; Yoshikawa T; Nabeshima M
    Hepatology; 2011 Sep; 54(3):1100-1. PubMed ID: 21793022
    [No Abstract]   [Full Text] [Related]  

  • 6. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.
    Danko JR; Gilliland WR; Miller RS; Decker CF
    Scand J Infect Dis; 2009; 41(4):252-5. PubMed ID: 19266397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
    Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG
    J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of lung tuberculosis in a patient with rheumatoid arthritis treated with infliximab after antituberculosis chemoprophylaxis with isoniazid.
    Hirano Y; Kojima T; Kanayama Y; Ishikawa H; Ishiguro N
    Mod Rheumatol; 2009; 19(3):323-8. PubMed ID: 19266254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach.
    Bassukas ID; Gaitanis G; Constantopoulos SH
    Eur Respir J; 2011 Jul; 38(1):231-2; author reply 232-3. PubMed ID: 21719504
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical cutaneous tuberculosis in a patient with rheumatoid arthritis treated with infliximab.
    Asano Y; Kano Y; Shiohara T
    Acta Derm Venereol; 2008; 88(2):183-4. PubMed ID: 18311458
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
    Seong SS; Choi CB; Woo JH; Bae KW; Joung CL; Uhm WS; Kim TH; Jun JB; Yoo DH; Lee JT; Bae SC
    J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of psoriasis induced by infliximab.
    Bal A; Gurcay E; Aydog E; Umay E; Tatlican S; Cakci A
    J Clin Rheumatol; 2008 Apr; 14(2):128-9; author reply 130. PubMed ID: 18391690
    [No Abstract]   [Full Text] [Related]  

  • 14. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis.
    Geraghty EM; Ristow B; Gordon SM; Aronowitz P
    Clin Infect Dis; 2007 May; 44(10):e82-4. PubMed ID: 17443458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
    Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
    Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of latent tuberculosis infection.
    De Rosa FG; Craven DE
    N Engl J Med; 2003 Mar; 348(13):1292-3; author reply 1292-3. PubMed ID: 12661576
    [No Abstract]   [Full Text] [Related]  

  • 17. Cryptococcal meningitis in a patient treated with infliximab.
    Muñoz P; Giannella M; Valerio M; Soria T; Díaz F; Longo JL; Bouza E
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):443-6. PubMed ID: 17240111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concerns regarding the readministration of tumor necrosis factor alpha antagonists following tuberculosis flare: comment on the concise communication by Aslanidis et al.
    Chogle AR; Mishra H; Deo SS
    Arthritis Rheum; 2008 Sep; 58(9):2923-4. PubMed ID: 18759280
    [No Abstract]   [Full Text] [Related]  

  • 19. A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment.
    Arend SM; Leyten EM; Franken WP; Huisman EM; van Dissel JT
    Clin Infect Dis; 2007 Dec; 45(11):1470-5. PubMed ID: 17990230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab.
    Fabre S; Gibert C; Lechiche C; Jorgensen C; Sany J
    J Rheumatol; 2005 Dec; 32(12):2432-3. PubMed ID: 16331777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.